These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34496632)

  • 1. Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity.
    Reynolds HR; Shaw LJ; Min JK; Page CB; Berman DS; Chaitman BR; Picard MH; Kwong RY; O'Brien SM; Huang Z; Mark DB; Nath RK; Dwivedi SK; Smanio PEP; Stone PH; Held C; Keltai M; Bangalore S; Newman JD; Spertus JA; Stone GW; Maron DJ; Hochman JS
    Circulation; 2021 Sep; 144(13):1024-1038. PubMed ID: 34496632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.
    Chaitman BR; Alexander KP; Cyr DD; Berger JS; Reynolds HR; Bangalore S; Boden WE; Lopes RD; Demkow M; Piero Perna G; Riezebos RK; McFalls EO; Banerjee S; Bagai A; Gosselin G; O'Brien SM; Rockhold FW; Waters DD; Thygesen KA; Stone GW; White HD; Maron DJ; Hochman JS;
    Circulation; 2021 Feb; 143(8):790-804. PubMed ID: 33267610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia: Secondary Analysis of the ISCHEMIA Randomized Clinical Trial.
    Reynolds HR; Shaw LJ; Min JK; Spertus JA; Chaitman BR; Berman DS; Picard MH; Kwong RY; Bairey-Merz CN; Cyr DD; Lopes RD; Lopez-Sendon JL; Held C; Szwed H; Senior R; Gosselin G; Nair RG; Elghamaz A; Bockeria O; Chen J; Chernyavskiy AM; Bhargava B; Newman JD; Hinic SB; Jaroch J; Hoye A; Berger J; Boden WE; O'Brien SM; Maron DJ; Hochman JS;
    JAMA Cardiol; 2020 Jul; 5(7):773-786. PubMed ID: 32227128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
    ; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y
    Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial.
    Reynolds HR; Cyr DD; Merz CNB; Shaw LJ; Chaitman BR; Boden WE; Alexander KP; Rosenberg YD; Bangalore S; Stone GW; Held C; Spertus J; Goetschalckx K; Bockeria O; Newman JD; Berger JS; Elghamaz A; Lopes RD; Min JK; Berman DS; Picard MH; Kwong RY; Harrington RA; Thomas B; O'Brien SM; Maron DJ; Hochman JS;
    J Am Heart Assoc; 2024 Mar; 13(5):e029850. PubMed ID: 38410945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA Trials.
    Newman JD; Anthopolos R; Ruggles KV; Cornwell M; Reynolds HR; Bangalore S; Mavromatis K; Held C; Wallentin L; Kullo IJ; McManus B; Newby LKK; Rosenberg Y; Hochman JS; Maron DJ; Berger JS;
    Am Heart J; 2023 Dec; 266():61-73. PubMed ID: 37604357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial.
    Chaitman BR; Cyr DD; Alexander KP; Pracoń R; Bainey KR; Mathew A; Acharya A; Kunichoff DF; Fleg JL; Lopes RD; Sidhu MS; Anthopolos R; Rockhold FW; Stone GW; Maron DJ; Hochman JS; Bangalore S
    Circ Cardiovasc Interv; 2022 Aug; 15(8):e012103. PubMed ID: 35973009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
    Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Coronary Artery Calcium in the PROMISE Study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain).
    Budoff MJ; Mayrhofer T; Ferencik M; Bittner D; Lee KL; Lu MT; Coles A; Jang J; Krishnam M; Douglas PS; Hoffmann U;
    Circulation; 2017 Nov; 136(21):1993-2005. PubMed ID: 28847895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score.
    Shlofmitz E; Généreux P; Chen S; Dressler O; Ben-Yehuda O; Morice MC; Puskas JD; Taggart DP; Kandzari DE; Crowley A; Redfors B; Mehdipoor G; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Circ Cardiovasc Interv; 2019 Sep; 12(9):e008007. PubMed ID: 31495220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial.
    Hochman JS; Reynolds HR; Bangalore S; O'Brien SM; Alexander KP; Senior R; Boden WE; Stone GW; Goodman SG; Lopes RD; Lopez-Sendon J; White HD; Maggioni AP; Shaw LJ; Min JK; Picard MH; Berman DS; Chaitman BR; Mark DB; Spertus JA; Cyr DD; Bhargava B; Ruzyllo W; Wander GS; Chernyavskiy AM; Rosenberg YD; Maron DJ;
    JAMA Cardiol; 2019 Mar; 4(3):273-286. PubMed ID: 30810700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial.
    Lopez-Sendon JL; Cyr DD; Mark DB; Bangalore S; Huang Z; White HD; Alexander KP; Li J; Nair RG; Demkow M; Peteiro J; Wander GS; Demchenko EA; Gamma R; Gadkari M; Poh KK; Nageh T; Stone PH; Keltai M; Sidhu M; Newman JD; Boden WE; Reynolds HR; Chaitman BR; Hochman JS; Maron DJ; O'Brien SM
    Eur Heart J; 2022 Jan; 43(2):148-149. PubMed ID: 34514494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.
    Chacko L; P Howard J; Rajkumar C; Nowbar AN; Kane C; Mahdi D; Foley M; Shun-Shin M; Cole G; Sen S; Al-Lamee R; Francis DP; Ahmad Y
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e006363. PubMed ID: 32063040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial.
    Pracoń R; Spertus JA; Broderick S; Bangalore S; Rockhold FW; Ruzyllo W; Demchenko E; Nageh T; Grossman GB; Mavromatis K; Manjunath CN; Smanio PEP; Stone GW; Mancini GBJ; Boden WE; Newman JD; Reynolds HR; Hochman JS; Maron DJ;
    Circ Cardiovasc Interv; 2024 Jun; 17(6):e013435. PubMed ID: 38629312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial.
    Lopes RD; Alexander KP; Stevens SR; Reynolds HR; Stone GW; Piña IL; Rockhold FW; Elghamaz A; Lopez-Sendon JL; Farsky PS; Chernyavskiy AM; Diaz A; Phaneuf D; De Belder MA; Ma YT; Guzman LA; Khouri M; Sionis A; Hausenloy DJ; Doerr R; Selvanayagam JB; Maggioni AP; Hochman JS; Maron DJ
    Circulation; 2020 Nov; 142(18):1725-1735. PubMed ID: 32862662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial.
    Bangalore S; Spertus JA; Stevens SR; Jones PG; Mancini GBJ; Leipsic J; Reynolds HR; Budoff MJ; Hague CJ; Min JK; Boden WE; O'Brien SM; Harrington RA; Berger JS; Senior R; Peteiro J; Pandit N; Bershtein L; de Belder MA; Szwed H; Doerr R; Monti L; Alfakih K; Hochman JS; Maron DJ;
    Circ Cardiovasc Interv; 2022 Apr; 15(4):e010925. PubMed ID: 35411785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER.
    Sabatine MS; De Ferrari GM; Giugliano RP; Huber K; Lewis BS; Ferreira J; Kuder JF; Murphy SA; Wiviott SD; Kurtz CE; Honarpour N; Keech AC; Sever PS; Pedersen TR
    Circulation; 2018 Aug; 138(8):756-766. PubMed ID: 29626068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
    Farzaneh-Far A; Phillips HR; Shaw LK; Starr AZ; Fiuzat M; O'Connor CM; Sastry A; Shaw LJ; Borges-Neto S
    JACC Cardiovasc Imaging; 2012 Jul; 5(7):715-24. PubMed ID: 22789940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of outcome in the ISCHEMIA-CKD trial: Anatomy versus ischemia.
    Bainey KR; Fleg JL; Hochman JS; Kunichoff DF; Anthopolos R; Chernyavskiy AM; Demkow M; Lopez-Quijano JM; Escobedo J; Poh KK; Ramos RB; Lima EG; Schuchlenz H; Ali ZA; Stone GW; Maron DJ; O'Brien SM; Spertus JA; Bangalore S
    Am Heart J; 2022 Jan; 243():187-200. PubMed ID: 34582775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival After Invasive or Conservative Management of Stable Coronary Disease.
    Hochman JS; Anthopolos R; Reynolds HR; Bangalore S; Xu Y; O'Brien SM; Mavromichalis S; Chang M; Contreras A; Rosenberg Y; Kirby R; Bhargava B; Senior R; Banfield A; Goodman SG; Lopes RD; Pracoń R; López-Sendón J; Maggioni AP; Newman JD; Berger JS; Sidhu MS; White HD; Troxel AB; Harrington RA; Boden WE; Stone GW; Mark DB; Spertus JA; Maron DJ;
    Circulation; 2023 Jan; 147(1):8-19. PubMed ID: 36335918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.